1996
DOI: 10.1006/abbi.1996.0470
|View full text |Cite
|
Sign up to set email alerts
|

Activation of p38 in Stimulated Human Neutrophils: Phosphorylation of the Oxidase Component p47 by p38 and ERK but Not by JNK

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

11
165
0
2

Year Published

1998
1998
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 231 publications
(178 citation statements)
references
References 0 publications
11
165
0
2
Order By: Relevance
“…In addition, the p38-kinase inhibitor SB-203580 totally inhibited phosphorylation and translocation of p47 phox and superoxide production. The demonstration that, in vitro, p38 kinase can phosphorylate p47 phox strengthens our hypothesis (36). Our results also suggest that p38-kinase activation in As 2 O 3 -treated macrophages involved the serine-threonine kinase ROCK; indeed, the ROCK inhibitor Y-27632 was found to prevent phosphorylation of p38 kinase and to mimic inhibitory effects of SB-203580 on NADPH oxidase activation: it markedly reduced phosphorylation of p47 phox , its membrane translocation, and superoxide production.…”
Section: Discussionsupporting
confidence: 87%
“…In addition, the p38-kinase inhibitor SB-203580 totally inhibited phosphorylation and translocation of p47 phox and superoxide production. The demonstration that, in vitro, p38 kinase can phosphorylate p47 phox strengthens our hypothesis (36). Our results also suggest that p38-kinase activation in As 2 O 3 -treated macrophages involved the serine-threonine kinase ROCK; indeed, the ROCK inhibitor Y-27632 was found to prevent phosphorylation of p38 kinase and to mimic inhibitory effects of SB-203580 on NADPH oxidase activation: it markedly reduced phosphorylation of p47 phox , its membrane translocation, and superoxide production.…”
Section: Discussionsupporting
confidence: 87%
“…It has been described that ERK and p38 MAPK phosphorylate p47 phox in human neutrophils [41] and that inhibitors of these kinases attenuate the neutrophil respiratory burst stimulated by a wide array of agonists [42,43]. Moreover, our group has shown that angiotensin II-dependent O ÅÀ 2 production becomes suppressed by specific inhibitors of the p38MAPK and ERK1/2 pathways [29].…”
Section: Resultsmentioning
confidence: 86%
“…Understanding the molecular mechanisms by which p38 MAPK participates in these responses is hindered by the limited number of targets of p38 MAPK identified to date in neutrophils. MAP-KAPK2 and p47 phox are the only clearly identified p38 MAPK targets in human neutrophils (1,9,10,21). A previous study by Lewis et al (45) determined that 20 of 25 ERK targets identified in a global screen were not previously known.…”
Section: Discussionmentioning
confidence: 97%
“…A number of p38 MAPK substrates have been identified previously in other cell types, including transcription factors such as activating transcription factor 2, kinases such as p38-regulated and -activated kinase and MAPKactivated protein kinase 2 (MAPKAPK-2), 3 and cell cycle regulators such as cyclin D (17)(18)(19)(20). The only p38 MAPK substrates that have been identified in human neutrophils, however, are MAP-KAPK-2 and p47 phox (1,9,10,21). The goal of the present study was to identify p38 MAPK substrates in human neutrophils using a functional proteomic approach developed in our laboratory that combines in vitro phosphorylation of neutrophil lysate by recombinant kinase, separation of proteins by two-dimensional gel electrophoresis, and phosphoprotein identification by MALDI-TOF mass spectrometry (MALDI-TOF MS) (22,23).…”
mentioning
confidence: 99%